The Daily Papule

Meeting abstracts

SID 2026

Society for Investigative Dermatology · Chicago, 13–16 May 2026

1,233 abstracts, published in JID on 21 July 2026. Their text is on the JID website.

  1. 0009

    Microbial antigen-driven cytotoxic CD8+ T cells mediate cutaneous immune-related adverse events during checkpoint blockade

    Chan JE, Younis S, … senior author Zaba L

  2. 0029

    Drug-induced morphea following complement c5 inhibition with zilucoplan: A case report

    Starr E, Behzadpour N, … senior author Emge D

  3. 0053

    Transcriptomic profiling defines core bullous pemphigoid immune programs and distinct keratinocyte-based signature in immune checkpoint inhibitor–induced disease

    Penner SE, Roberts BT, … senior author Mangold AR

  4. 0089

    Identifying culprit drugs in inpatient drug-induced rashes using large language models

    Lee J, Huang Y, … senior author Gelfand J

  5. 0090

    Human-in-the-Loop LLM for faster and more reliable identification of cutaneous immune-related adverse events

    Lu C, Burke O, … senior author Semenov Y

  6. 0178

    Ivig: An unlikely culprit of fixed drug eruption

    Chinyere T, Crandall M

  7. 0194

    Enfortumab vedotin-induced cutaneous toxicities and their downstream impact on survival in urothelial carcinoma

    Lee E, Karagenova R, … senior author Semenov Y

  8. 0274

    Cutaneous adverse events of bispecific antibody talquetamab are associated with lower all-cause mortality in multiple myeloma

    Corey S, Patil MK, … senior author Chen S

  9. 0329

    Simultaneous leukocytoclastic vasculitis and morbilliform drug eruption in a patient on dual immune checkpoint blockade: A case report

    Block BR, Mehta J, … senior author Brownstone N

  10. 0358

    Diagnostic value of skin testing in evaluation of delayed drug reactions

    Zhang R, Hanka A, … senior author Bigliardi P

  11. 0367

    Hidradenitis suppurativa and HS-like cutaneous adverse events associated with γ-secretase inhibitors

    McCaffrey T, Li A, … senior author Garza LA

  12. 0373

    Seasonality and trends in Stevens-Johnson syndrome and toxic epidermal necrolysis before and during the COVID-19 pandemic

    Mukherjee EM, Park D, … senior author Phillips E

  13. 0377

    Atrial fibrillation and flutter are associated with increased morbidity and mortality in hospitalized patients with stevens-johnson syndrome and toxic epidermal necrolysis

    Abidi Z, Mazhar MA, Abidi H

  14. 0384

    Drug-induced subacute cutaneous lupus erythematosus: Real-world outcomes

    Orofino J, Whittelsey M, … senior author LaChance A

  15. 0388

    Beyond beta-lactams: antifungals as a high-risk trigger for AGEP in an international cohort study

    Ristianto ZN, Martin MR, Femia AN

  16. 0393

    Clinical and histopathologic characterization and management of dermatologic immune-related adverse events from immune checkpoint inhibitors

    Longo LO, Trieu B, … senior author Dang T

  17. 0394

    Cyclosporine in SJS/TEN: A U.S. claims-based cohort study

    Rubenstein AI, Blewitt C, … senior author Fajgenbaum D

  18. 0432

    Cutaneous graft-versus-host disease versus ruxolitinib-induced acneiform eruption in a hematopoietic stem cell transplant recipient: A diagnostic conundrum

    Mehta J, Block BR, … senior author Farabi B

  19. 0484

    Outcomes following IL-5 inhibition in drug reaction with eosinophilia and systemic symptoms (DRESS): A retrospective cohort study

    Thompson B, Corey S, … senior author Chen S

  20. 0500

    Cutaneous toxicities of inhibitors across the MAPK signaling pathway

    Lee E, McCaffrey T, Guggina L

  21. 0508

    Isotretinoin and acitretin for EGFR-, MEK-, and BRAF-inhibitor associated acneiform eruptions: A 10-year multicenter retrospective analysis

    Patil MK, Kanwar R, … senior author Shi CR

  22. 0513

    The use of topical roflumilast in the treatment of localized, steroid-refractory cutaneous immune-related adverse events: A single-institution real-life study

    Block BR, Mehta J, … senior author Gulati N

  23. 0514

    Ninety-day mortality following systemic corticosteroids versus steroid-sparing immunomodulators for Stevens-Johnson syndrome/toxic epidermal necrolysis

    Block BR, Mehta J, … senior author Gulati N

  24. 0524

    Drug-induced vitiligo: Analysis of the FDA adverse event reporting system

    Rahman M, Marquez CR, … senior author Shi VY

  25. 0595

    Skin commensals reduce AhR-mediated skin toxicity induced by polycyclic aromatic hydrocarbons

    Minzaghi DC, Huang S, … senior author Knight S

  26. 0735

    Higher income quartile is associated with lower inpatient mortality and complications in stevens–johnson syndrome/toxic epidermal necrolysis

    Abidi H, Mazhar MA, … senior author Abidi Z

  27. 0768

    Demographic disparities in diagnosis of cutaneous immune-related adverse events: A TriNetX study

    Mehta J, Block BR, … senior author Gulati N

  28. 1075

    Tape-strip transcriptomic profiling of morbilliform drug eruptions reveals activation of multiple T-cell subsets and potential therapeutic targets

    Mehta J, Rabinowitz G, … senior author Gulati N

That's every abstract.